[1] 王谷云,姚红霞. 慢性粒细胞白血病的治疗进展[J]. 医学综述, 2009,15(13):1998-2000. [2] 沈君, 王开泰,陆红娟. 慢性粒细胞白血病的诊断与治疗[J]. 中国实用内科杂志, 2008,28(S1):203-205. [3] Von Bubnoff N, Duyster J. Chronic myelogenous leukemia: treatment and monitoring [J]. Dtsch Arztebl Int, 2010, 107(7):114-121. [4] Wadleigh M, Tefferi A. Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria [J]. Int J Hematol, 2010, 91(2):174-179. [5] 刘玲玲, 韩跃武, 祝凯平, 等. 慢性髓细胞性白血病K562细胞适体的筛选与鉴定 [J]. 医学争鸣, 2009, 30(13):1157-1160. [6] Meng L, Sefah K, Colon DL, et al. Using live cells to generate aptamers for cancer study [J]. Methods Mol Biol, 2010, 629:355-367. [7] 查成喜, 韩跃武, 张雪燕, 等. 基于ssDNA适配子的慢性粒细胞白血病K562细胞检测方法的建立 [J]. 中国生物制品学杂志, 2011, 24(7):845-848. [8] Armitage P, Colton T. Encyclopedia of biostatistics [M]. New York: John, 1998: 3738-3744. [9] Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations [J]. Stat Med, 1993, 12(14):1293-1316. [10] 杨有业,张秀明. 临床检验方法学评价[M]. 北京:人民卫生出版社,2008:81-100. |